Latest News

Chemo-radionuclide therapy halts neuroendocrine cancer

Advanced cancer of the neuroendocrine system can lead to dismal prognoses, but a novel therapy is packing a punch by uniting powerful radionuclide treatment and chemotherapy drugs, revealed researchers. Neuroendocrine tumors (NETs) are those that develop within a multiplicity of organs throughout the body that have nerve cells and interact with the endocrine system through chemical signaling made possible with various hormones. These tumors usually develop along the intestines and lungs, but they can also be found in the pancreas and many other sites.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Protein Elevated in Blood Predicts Post-Concussion Symptom Severity in Professional Athletes

  • Entrepreneurs to venture capitalists: Don?t be a Scrooge

  • Pain in a dish: Researchers turn skin cells into pain sensing neurons

  • Better assessment of decision-making capacity

  • Problem gambling, personality disorders often go hand in hand

  • Gene discovered that reduces risk of stroke

  • Homosexuality may help us bond, experts say

  • Asymptomatic atherosclerosis linked to cognitive impairment

  • How environment contributes to several human diseases

  • Alzheimer's in a dish model converts skin cells to induced neurons expressing amyloid-beta and tau

  •